Vimarsana
Biggest News Aggregation in the World

Page 2 - Greg Mayes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Mayes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Mayes Today - Breaking & Trending Today

City agrees to explore Joint Municipal Authority | News, Sports, Jobs - Vimarsana News

City agrees to explore Joint Municipal Authority | News, Sports, Jobs

LOCK HAVEN — The City of Lock Haven is open to joining talks about a Joint Municipal Authority with other water entities in the area. Lock Haven City Counci

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic - Mindset Pharma (OTC:MSSTF) - Vimarsana News

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic - Mindset Pharma (OTC:MSSTF)

Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.) 

Reunion Neuroscience : Annual Information Form For the Fiscal Year Ended March 31, 2023 - Vimarsana News

Reunion Neuroscience : Annual Information Form For the Fiscal Year Ended March 31, 2023

Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...

Reunion Neuroscience : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Reunion Neuroscience : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 12, 2023 AND MANAGEMENT INFORMATION CIRCULAR JUNE 13, 2023 ... | June 20, 2023

Reunion Neuroscience : Announces US$13.1 Million Take-Private Transaction with MPM BioImpact - Form 6-K - Vimarsana News

Reunion Neuroscience : Announces US$13.1 Million Take-Private Transaction with MPM BioImpact - Form 6-K

Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact Reunion Common Shareholders to Receive Consideration of US$1.12 Per Share in Cash ... | June 1, 2023